Will mandatory folic acid fortification prevent or promote cancer?

American Journal of Clinical Nutrition

Volumn 80, Issue 5, 2004, Pages 1123-1128

  Kim, Young In ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Cancer; Carcinogenesis; DNA methylation; Folate; Folic acid fortification; Neural tube defects

Indexed keywords

FOLIC ACID;

CANCER; CANCER PREVENTION; HEALTH CARE POLICY; HUMAN; MONITORING; NEURAL TUBE DEFECT; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; SAFETY; SUPPLEMENTATION; TUMOR PROMOTION; ANIMAL; CHEMICALLY INDUCED DISORDER; DIET SUPPLEMENTATION; DNA METHYLATION; DRUG EFFECT; NEOPLASM; NEWBORN;

ANIMALS; DNA METHYLATION; FOLIC ACID; FOOD, FORTIFIED; HUMANS; INFANT, NEWBORN; NEOPLASMS; NEURAL TUBE DEFECTS;

EID: 16544370325     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/80.5.1123     Document Type: Review

References (61)

1. Kim YI. Role of folate in colon cancer development and progression. J Nutr 2003;133:3731S-9S.
2. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
3. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7.
4. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999;341:1485-90. (Published erratum appears in N Engl J Med 1999;341:1864.)
5. Bailey LB, Rampersaud GC, Kauwell GP. Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: evolving science. J Nutr 2003;133:1961S-8S.
6. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992;41:1-7.
7. Institute of Medicine. Folate. In: Dietary reference intakes for thiamin, roboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academy Press, 1998:196-305.
8. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final rule. 21 CFR Parts 136, 137, and 139. Fed Regist 1996;61:8781-807.
9. Health Canada. Regulations amending the Food and Drug Regulations (1066). Can Gaz Part 1 1997;131:3702-37.
10. Freire WB, Hertrampf E, Cortes F. Effect of folic acid fortification in Chile: preliminary results. Eur J Pediatr Surg 2000;10(suppl):42-3.
11. Metz J, Sikaris KA, Maxwell EL, Levin MD. Changes in serum folate concentrations following voluntary food fortification in Australia. Med J Aust 2002;176:90-1.
12. Centers for Disease Control and Prevention. Folate status in women of childbearing age - United States. MMWR Morb Mortal Wkly Rep 2000;49:962-5.
13. Choumenkovitch SF, Jacques PF, Nadeau MR, Wilson PW, Rosenberg IH, Selhub J. Folic acid fortification increases red blood cell folate concentrations in the Framingham study. J Nutr 2001;131:3277-80.
14. Choumenkovitch SF, Selhub J, Wilson PW, Rader JI, Rosenberg IH, Jacques PF. Folic acid intake from fortification in United States exceeds predictions. J Nutr 2002;132:2792-8.
15. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-54.
16. Lawrence JM, Petitti DB, Watkins M, Umekubo MA. Trends in serum folate after food fortification. Lancet 1999;354:915-6.
17. Ray JG, Vermeulen MJ, Boss SC, Cole DE. Increased red cell folate concentrations in women of reproductive age after Canadian folic acid food fortification. Epidemiology 2002;13:238-40.
18. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981-6.
19. Williams LJ, Mai CT, Edmonds LD, et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 2002;66:33-9.
20. Gucciardi E, Pietrusiak MA, Reynolds DL, Rouleau J. Incidence of neural tube defects in Ontario, 1986-1999. CMAJ 2002;167:237-40.
21. Persad VL, Van den Hof MC, Dube JM, Zimmer P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 2002;167:241-5.
22. Bower C, Ryan A, Rudy E, Miller M. Trends in neural tube defects in Western Australia. Aust N Z J Public Health 2002;26:150-1.
23. De Wals P, Rusen ID, Lee NS, Morin P, Niyonsenga T. Trend in prevalence of neural tube defects in Quebec. Birth Defects Res Part A Clin Mol Teratol 2003;67:919-23.
24. Shane B. Folate fortification: enough already? Am J Clin Nutr 2003;77:8-9.
25. Campbell NR. How safe are folic acid supplements? Arch Intern Med 1996;156:1638-44.
26. Oakley GP Jr. Inertia on folic acid fortification: public health malpractice. Teratology 2002;66:44-54.
27. Stevenson RE, Allen WP, Pai GS, et al. Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics 2000;106:677-83.
28. French AE, Grant R, Weitzman S, et al. Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther 2003;74:288-94.
29. Bunin GR, Kuijten RR, Buckley JD, Rorke LB, Meadows AT. Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med 1993;329:536-41.
30. Preston-Martin S, Pogoda JM, Mueller BA, et al. Prenatal vitamin supplementation and risk of childhood brain tumors. Int J Cancer Suppl 1998;11:17-22.
31. Olshan AF, Smith JC, Bondy ML, Neglia JP, Pollock BH. Maternal vitamin use and reduced risk of neuroblastoma. Epidemiology 2002;13:575-80.
32. Kim YI. Folate and carcinogenesis: Evidence, mechanisms, and implications. J Nutr Biochem 1999;10:66-88.
33. Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 2002;132:2413S-8S.
34. Little PA, Sampath A, Paganelli V. The effect of folic acid and its antagonists on rous chicken sarcoma. Trans N Y Acad Sci Ser II 1948;10:91-8.
35. Rosen F. Inhibition of the growth of an amethopterin-refractory tumor by dietary restriction of folic acid. Cancer Res 1962;22:495-500.
36. Bills ND, Hinrichs SH, Morgan R, Clifford AJ. Delayed tumor onset in transgenic mice fed a low-folate diet. J Natl Cancer Inst 1992;84:332-7.
37. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 2002;132:2350S-5S.
38. Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998;129:517-24.
39. Jacobs EJ, Connell CJ, Patel AV, et al. Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States). Cancer Causes Control 2001;12:927-34.
40. Kim YI, Salomon RN, Graeme-Cook F, et al. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut 1996;39:732-40.
41. Le Leu RK, Young GP, McIntosh GH. Folate deficiency reduces the development of colorectal cancer in rats. Carcinogenesis 2000;21:2261-5.
42. Wargovich MJ, Chen CD, Jimenez A, et al. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev 1996;5:355-60.
43. Song J, Medline A, Mason JB, Gallinger S, Kim YI. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res 2000;60:5434-40.
44. -/- mice. Cancer Res 2000;60:3191-9.
45. Baggott JE, Vaughn WH, Juliana MM, Eto I, Krumdieck CL, Grubbs CJ. Effects of folate deficiency and supplementation on methylnitrosourea-induced rat mammary tumors. J Natl Cancer Inst 1992;84:1740-4.
46. Kotsopoulos J, Sohn KJ, Martin R, et al. Dietary folate deficiency suppresses N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Carcinogenesis 2003;24:937-44.
47. Farber S. Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood 1949;4:160-7.
48. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
49. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
50. Lewis CJ, Crane NT, Wilson DB, Yetley EA. Estimated folate intakes: data updated to reflect food fortification, increased bioavailability, and dietary supplement use. Am J Clin Nutr 1999;70:198-207.
51. Rader JI, Weaver CM, Angyal G. Total folate in enriched cereal-grain products in the United States following fortification. Food Chem 2000;70:275-89.
52. Quinlivan EP, Gregory JF III. Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr 2003;77:221-5.
53. Kamen B. Folate and antifolate pharmacology. Semin Oncol 1997;24(suppl):S18-30-18-39.
54. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28.
55. Kim YI. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 2004;13:511-9.
56. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003;23:5293-300.
57. Yoder JA, Walsh CP, Bestor TH. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 1997;13:335-40.
58. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
59. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
60. Winawer SJ. A quarter century of colorectal cancer screening: progress and prospects. J Clin Oncol 2001;19:6S-12S.
61. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med 1999;341:1509-19.